• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期驻留的脂肪来源基质干细胞在微环境重塑中使膀胱癌细胞干性和上皮-间质转化增强,从而促进膀胱癌进展。

Long-term resident adipose-derived stromal stem cells in the microenvironment remodeling BLCA cell stemness and EMT promotes bladder cancer progression.

作者信息

Huang Denggao, Guo Na, Peng Yanling, Nie Zhenyu, Gao Yuanhui, Cao Hui, Wang Shunlan, Chen Mei, Wen Xiaohong, Wang Zhaojun, Zheng Linlin, He Haowei, Sun Yong, Chen Yang, Zhang Shufang

机构信息

Central Laboratory, Haikou Affiliated Hospital of Central South University Xiangya School of Medical, Haikou, Hainan, 570208, P. R. China.

Haikou City Key Laboratory of Clinical Medicine, Haikou, Hainan, 570208, P. R. China.

出版信息

Sci Rep. 2025 Jul 2;15(1):23049. doi: 10.1038/s41598-025-07387-7.

DOI:10.1038/s41598-025-07387-7
PMID:40596589
Abstract

The role of adipose-derived stromal stem cells (ADSCs) in BLCA progression is unclear. We investigated the effects of invasion, stemness, Epithelial-mesenchymal transition (EMT), and drug resistance of BLCA cells co-cultured with ADSCs for a long period of time. Cells were divided into six groups: ADSCs group, ADSCs: T24 group (10:1, 3:1 and 1:1 groups), ADSCs-derived conditioned medium group (CM) and T24 cell group (T24), and cells in each group were cultured to 14 days, and puromycin (puro) was added to the co-cultured cell to remove ADSCs cells without puro resistance, and then the function of T24 cells (10:1-COC, 3:1-COC and 1:1-COC) after co-culture was studied; CCK-8 assay, Transwell, Wound healing, Flow cytometry, RNA-sequencing, qRT-PCR and Western Bloting assay were used to detect cell proliferation, invasion, migration, apoptosis and cellular mRNA and protein expression levels, respectively. We unexpectedly found enhanced stemness and drug resistance of BLCA cells after prolonged contact culture with ADSCs. T24 cells after co-culture mediated cell proliferation, invasion, EMT, stemness, drug resistance and immune escape by up-regulating MDM2, mt-P53 and PD-L1, compared to CM and T24 groups. The inhibitor Atezo and CP-31,398 eliminated mt-P53 and PD-L1-mediated T24 cell drug resistance and stemness, respectively. This study demonstrated that after prolonged co-culture of BLCA cells with ADSCs, the stemness, drug resistance, and immune evasion of T24 cells were dramatically enhanced, suggesting that long-term resident ADSCs in the bladder cancer tumor microenvironment play a procarcinogenic role.

摘要

脂肪来源的间充质干细胞(ADSCs)在膀胱癌(BLCA)进展中的作用尚不清楚。我们研究了长时间与ADSCs共培养的BLCA细胞的侵袭、干性、上皮-间质转化(EMT)和耐药性。细胞分为六组:ADSCs组、ADSCs:T24组(10:1、3:1和1:1组)、ADSCs来源的条件培养基组(CM)和T24细胞组(T24),每组细胞培养至14天,向共培养细胞中加入嘌呤霉素(puro)以去除无嘌呤霉素抗性的ADSCs细胞,然后研究共培养后T24细胞(10:1-COC、3:1-COC和1:1-COC)的功能;分别使用CCK-8检测、Transwell实验、伤口愈合实验、流式细胞术、RNA测序、qRT-PCR和蛋白质免疫印迹实验来检测细胞增殖、侵袭、迁移、凋亡以及细胞mRNA和蛋白质表达水平。我们意外地发现,与ADSCs长时间接触培养后,BLCA细胞的干性和耐药性增强。与CM组和T24组相比,共培养后的T24细胞通过上调MDM2、线粒体P53(mt-P53)和程序性死亡受体配体1(PD-L1)介导细胞增殖、侵袭、EMT、干性、耐药性和免疫逃逸。抑制剂阿替利珠单抗(Atezo)和CP-31,398分别消除了mt-P53和PD-L1介导的T24细胞耐药性和干性。本研究表明,BLCA细胞与ADSCs长期共培养后,T24细胞的干性、耐药性和免疫逃逸显著增强,提示长期驻留在膀胱癌肿瘤微环境中的ADSCs发挥促癌作用。

相似文献

1
Long-term resident adipose-derived stromal stem cells in the microenvironment remodeling BLCA cell stemness and EMT promotes bladder cancer progression.长期驻留的脂肪来源基质干细胞在微环境重塑中使膀胱癌细胞干性和上皮-间质转化增强,从而促进膀胱癌进展。
Sci Rep. 2025 Jul 2;15(1):23049. doi: 10.1038/s41598-025-07387-7.
2
DSG3 promotes bladder cancer growth and metastasis via AKT/GSK3β/β-catenin pathway.桥粒芯糖蛋白3(DSG3)通过AKT/糖原合成酶激酶3β/β-连环蛋白信号通路促进膀胱癌的生长和转移。
J Transl Med. 2025 Jul 2;23(1):729. doi: 10.1186/s12967-025-06754-2.
3
BAIAP2 as a driver of tumor progression in urothelial bladder cancer.BAIAP2作为尿路上皮膀胱癌肿瘤进展的驱动因素。
BMC Cancer. 2025 Jul 1;25(1):1057. doi: 10.1186/s12885-025-14470-9.
4
Paeonol regulates glycolytic metabolism by downregulating BACH1 to ameliorate stemness, angiogenesis, and EMT in SiHa cervical cancer cells.丹皮酚通过下调BACH1调节糖酵解代谢,以改善SiHa宫颈癌细胞的干性、血管生成和上皮-间质转化。
Histol Histopathol. 2025 Jul;40(7):1105-1115. doi: 10.14670/HH-18-844. Epub 2024 Nov 5.
5
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
6
Pathway-based cancer transcriptome deciphers a high-resolution intrinsic heterogeneity within bladder cancer classification.基于通路的癌症转录组解析膀胱癌分类中的高分辨率内在异质性。
J Transl Med. 2025 Jun 17;23(1):666. doi: 10.1186/s12967-025-06682-1.
7
Hypoxia-induced HIF-1α/VASN promotes bladder cancer progression.缺氧诱导的HIF-1α/VASN促进膀胱癌进展。
Sci Rep. 2025 Jul 1;15(1):21635. doi: 10.1038/s41598-025-05929-7.
8
Cell Imprint-Mediated Differentiation of Adipose-Derived Stem Cells Into Keratinocytes Enhances Wound Healing on Collagen-Based Scaffolds: An Ovine Model Study.细胞印记介导脂肪干细胞向角质形成细胞分化增强基于胶原蛋白支架的伤口愈合:一项绵羊模型研究
Wound Repair Regen. 2025 May-Jun;33(3):e70037. doi: 10.1111/wrr.70037.
9
Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.脐带间充质干细胞通过激活ERK信号通路促进MCF-7和MDA-MB-231乳腺癌细胞的增殖和迁移。
Oncol Rep. 2015 Sep;34(3):1469-77. doi: 10.3892/or.2015.4109. Epub 2015 Jul 3.
10
The effects of Stem Cell-Conditioned Media on Malignancy Behavior of Breast Cancer Cells .干细胞条件培养基对乳腺癌细胞恶性行为的影响
Arch Razi Inst. 2024 Dec 31;79(6):1249-1256. doi: 10.32592/ARI.2024.79.6.1249. eCollection 2024 Dec.

本文引用的文献

1
Incidence and Pitfalls of Adipose Tissue Encountered in Urinary Bladder Biopsy/Transurethral Resection Specimens.膀胱活检/经尿道切除标本中脂肪组织的发生率及陷阱
Int J Surg Pathol. 2025 May;33(3):596-604. doi: 10.1177/10668969241271957. Epub 2024 Sep 19.
2
Classifying cancer-associated fibroblasts-The good, the bad, and the target.分类癌症相关成纤维细胞——好的、坏的和靶向的。
Cancer Cell. 2024 Sep 9;42(9):1480-1485. doi: 10.1016/j.ccell.2024.08.011.
3
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9.
4
Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy.MDM2 作为一种全面泛癌分析中的预后和免疫治疗生物标志物的鉴定:乳腺癌、膀胱癌和卵巢癌免疫治疗的有希望的靶点。
Life Sci. 2023 Aug 15;327:121832. doi: 10.1016/j.lfs.2023.121832. Epub 2023 Jun 3.
5
Obesity, the Adipose Organ and Cancer in Humans: Association or Causation?肥胖、脂肪组织与人类癌症:关联还是因果关系?
Biomedicines. 2023 Apr 28;11(5):1319. doi: 10.3390/biomedicines11051319.
6
Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.膀胱癌中的癌相关成纤维细胞:起源、生物学和治疗机会。
Eur Urol Oncol. 2023 Aug;6(4):366-375. doi: 10.1016/j.euo.2023.02.011. Epub 2023 Mar 6.
7
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
8
Obesity influence on bladder inflammation and cancer: a cystitis model.肥胖对膀胱炎症和癌症的影响:膀胱炎模型
Int J Clin Exp Pathol. 2022 Sep 15;15(9):373-379. eCollection 2022.
9
The dynamic roles of the bladder tumour microenvironment.膀胱肿瘤微环境的动态作用。
Nat Rev Urol. 2022 Sep;19(9):515-533. doi: 10.1038/s41585-022-00608-y. Epub 2022 Jun 28.
10
Emerging treatment landscape of non-muscle invasive bladder cancer.非肌肉浸润性膀胱癌的新兴治疗领域。
Expert Opin Biol Ther. 2022 Jun;22(6):717-734. doi: 10.1080/14712598.2022.2082869. Epub 2022 May 31.